NEW YORK, June 17, 2013 \/PRNewswire\/ -- Reportlinker.com announces that a new market research report is available in its catalogue: <\/p>\n
Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and Other Testing) <\/p>\n
http:\/\/www.reportlinker.com\/p01360928\/Personalized-Medicine-Diagnostics-Flow-Cytometry-Sepsis-Immunos-Routine-Coagulation-Psychiatric-Disorders-Tumor-Markers-Molecular-Blood-Typing-and-Other-Testing.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic<\/a><\/p>\n Personalized Medicine Diagnostics - Market Overview <\/p>\n Personalized Medicine is often defined as \"the right treatment for the right person at the right time.\" Personalized medicine is becoming the place to be in clinical diagnostics as well and slowly becoming the reality of future in the diagnostics industry <\/p>\n By Technology Segment - Personalized Medicine diagnostics market is expected to grow with a double digit CAGR for the period of 2013 to 2018. It is expected that personalized medicine diagnostics market by technology is going to double by 2018 from its current market size in 2012. In this segment, Point of Care Testing and Molecular Diagnostics segments control the #1 and #2 positions in 2012. <\/p>\n By Diseases Segment - Personalized Medicine diagnostics market is expected to be more than US$ 30 Billion by 2018. Diabetes management test and Cancer management test are the leading market in this segment. <\/p>\n Renub Research report entitled \"Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and Other Testing)\" report provides a comprehensive analysis of the emerging personalized medicine diagnostic market segments, including their dynamics, size, market share, key investors, clinical trials statement, technological trends, company analysis and a realistic future potential for personalized medicine in clinical testing. The report also entails major drivers and challenges of personalized medicine diagnostic market. This 173 page report contains 94 Figures and 16 Tables studies the Personalized Medicine Diagnostics Market. This report contains 12 chapters <\/p>\n Chapter 1 is Executive Summary <\/p>\n Chapter 2 contains worldwide personalized medicine diagnostic market & forecast (2011 2018). The market includes technological & disease-wise personalized medicine diagnostics market <\/p>\n <\/p>\n Continue reading here:<\/p>\n Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor ...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" NEW YORK, June 17, 2013 \/PRNewswire\/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and Other Testing) http:\/\/www.reportlinker.com\/p01360928\/Personalized-Medicine-Diagnostics-Flow-Cytometry-Sepsis-Immunos-Routine-Coagulation-Psychiatric-Disorders-Tumor-Markers-Molecular-Blood-Typing-and-Other-Testing.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic<\/a> Personalized Medicine Diagnostics - Market Overview Personalized Medicine is often defined as \"the right treatment for the right person at the right time.\" Personalized medicine is becoming the place to be in clinical diagnostics as well and slowly becoming the reality of future in the diagnostics industry By Technology Segment - Personalized Medicine diagnostics market is expected to grow with a double digit CAGR for the period of 2013 to 2018. It is expected that personalized medicine diagnostics market by technology is going to double by 2018 from its current market size in 2012. In this segment, Point of Care Testing and Molecular Diagnostics segments control the #1 and #2 positions in 2012. Continue reading